Use of Immunosuppressive Therapy for Sarcoidosis

• Conditions: Sarcoidosis
• Interventions: Other: Cytotoxic drug

• Registration Number: NCT02356445
• Lead Sponsor: University of Cincinnati

Brief Summary

Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis

Detailed Description

Patients receiving one or more cytotoxic or other immunosuppressive drug will be observed

Study Timeline

• Study Start: 2014-11
• Study First Submitted: 2014-11-03
• Study First Submitted QC: 2015-02-01
• Study First Posted: 2015-02-05
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-10
• Last Update Posted: 2017-08-14
• Primary Completion: 2018-11
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Any patient treated for sarcoidosis

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cytotoxic drug	Cytotoxic drug	Patients treated for sarcoidosis

Primary Outcome Measures

Name	Time	Method
Clinical Outcome	2 years	Number of participants with improvement over two years

Secondary Outcome Measures

Name	Time	Method
Toxicity	2 years	Number of participants with adverse events

Trial Locations

Locations (1)

University of Cincinnati; 🇺🇸 Cincinnati, Ohio, United States